Home > Keywords >
| Catalog | name | Description | price |
|---|---|---|---|
| R-C-642 | PD153035HCl CAS No. 183322-45-4 | PD153035 HCl(SU-5271 HCl,AG1517 HCl,ZM 252868 HCl) is a potent and specific inhibitor of EGFR with Ki and IC50 of 5.2 pM and 29 pM in cell-free assays; little effect noted against PGDFR,FGFR,CSF-1,InsR and Src. | price> |
| R-R-2342 | (R,R)-VVD-118313 CAS No.2875046-31-2 | (R,R)-VVD-118313/CAS No.2875046-31-2 is the isomer of VVD-118313 (HY-151385). VVD-118313 is a selective JAK1 inhibitor and blocks JAK1-dependent trans-phosphorylation and cytokine signaling. VVD-118313 can be used for research of cancer. (R,R)-VVD-118313 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups. | price> |
| R-C-643 | BIX02188 CAS:1094614-84-2 | BIX02188 is a potent MEK5-selective inhibitor with an IC50 of 4.3 nM.BIX02188 inhibits ERK5 catalytic activity,with an IC50 of 810 nM. | price> |
| R-R-2343 | GDC-4379 CAS No.2252277-73-7 | GDC-4379/CAS No.2252277-73-7 is a JAK1 inhibitor that can be used for the research of asthma. | price> |
| R-C-644 | BIX02189 CAS:1094614-85-3 | BIX02189 is a selective inhibitor of MEK5 with IC50 of 1.5 nM,also inhibits ERK5 catalytic activity with IC50 of 59 nM in cell-free assays,and does not inhibit closely related kinases MEK1,MEK2,ERK2,and JNK2. | price> |
| R-R-2344 | Tubulin/JAK2-IN-1 CAS No.2933938-46-4 | Tubulin/JAK2-IN-1 (compound 7g)/CAS No.2933938-46-4 is a dual inhibitor of Janus kinase 2 (JAK2) and microtubule. Tubulin/JAK2-IN-1 has potent antiproliferative activity against the cancer cells. | price> |
| R-C-645 | CP945598(Otenabant ) cas:686344-29-6 | Otenabant is a potent and selective cannabinoid receptor CB1 antagonist with Ki of 0.7 nM,exhibits 10,000-fold greater selectivity against human CB2 receptor. | price> |
| R-R-2345 | Tyk2-IN-8 CAS No.2704587-24-4 | Tyk2-IN-8/CAS No.2704587-24-4 is a selective Tyk-2 inhibitor with an IC50 of 5.7 nM for TYK2-JH2. Tyk2-IN-8 inhibits JAK1-JH1 with IC50 of 3.0 nM. Tyk2-IN-8 can be used for the research of autoimmune disease. | price> |
| R-C-646 | GW9508 cas:885101-89-3 | GW 9508 is a cell-permeable aminophenylpropanoate that acts as a potent and selective agonist for the G-protein coupled receptor(GPCR)GRP40/FFA1 receptor (EC50 ?50 nM)with reduced activity towards family members GRP120 (EC50?3.5 μM), GRP41/GRP43 (EC50>50 μM),as well as a panel of eight other free fatty acid (FFA) and prostaglandin receptors. | price> |
| R-R-2346 | Filgotinib-d4 CAS No.2041095-50-3 | Filgotinib-d4/CAS No.2041095-50-3 is the deuterium labeled Filgotinib. Filgotinib (GLPG0634) is a selective JAK1 inhibitor with IC50 of 10 nM, 28 nM, 810 nM, and 116 nM for JAK1, JAK2, JAK3, and TYK2, respectively. | price> |
| R-C-647 | CI994 cas:112522-64-2 | Tacedinaline(N-acetyldinaline)is an inhibitor of the histone deacetylase(HDAC) with IC50s of 0.9,0.9,1.2μM for recombinant HDAC 1,2 and 3 respectively. | price> |
| R-R-2347 | LFM-A13 CAS No.62004-35-7 | LFM-A13/CAS No.62004-35-7 is a potent BTK, JAK2, PLK inhibitor, inhibits recombinant BTK, Plx1 and PLK3 with IC50s of 2.5 μM, 10 μM and 61 μM. LFM-A13 has antiproliferative activity and anticancer activity. LFM-A13 can be used in cancer-related research. | price> |
| R-C-648 | AT7519HCL cas:902135-91-5 | AT7519 Hydrochloride is a potent inhibitor of CDKs,with IC50s of 210,47,100,13, 170,and <10 nM for CDK1,CDK2,CDK4 to CDK6,and CDK9,respectively. | price> |
| R-R-2348 | (3R,4S)-Tofacitinib CAS No.1092578-46-5 | (3R,4S)-Tofacitinib/CAS No.1092578-46-5 is an less active enantiomer of Tofacitinib. Tofacitinib inhibits JAK3 with IC50 of 1 nM. | price> |
| R-C-649 | StemRegenin 1 (SR1) CAS No. 1227633-49-9 | StemRegenin 1(SR1)is a cell-permeable purine derivative that acts as an antagonist of aryl hydrocarbon receptor and promotes the self-renewal of hematopoietic stem cells (HSCs). | price> |
| R-R-2349 | Fosifidancitinib CAS No.1237168-58-9 | Fosifidancitinib/CAS No.1237168-58-9 is a potent and selective inhibitor of JAK kinases 1/3. Fociatinib is used in studies of allergies, asthma and autoimmune diseases. | price> |
| R-C-650 | KI8751 cas:228559-41-9 | Ki8751 is a cell-permeable quinolyloxyphenyl-urea compound that acts as a Flk-1 (VEGFR-2)-selective inhibitior in both cell-based and cell-free assays. | price> |
| R-R-2350 | Nimucitinib CAS No.2740557-24-6 | Nimucitinib/CAS No.2740557-24-6 is a Janus kinase (JAK) inhibitor. | price> |
| R-C-651 | Rociletinib (CO-1686) cas:1374640-70-6 | Rociletinib(CO-1686,AVL-301)is an irreversible,mutant-selective EGFR inhibitor with Ki of 21.5 nM and 303.3 nM for EGFRL858R/T790M and EGFRWT in cell-free assays,respectively. | price> |
| R-R-2351 | (Rac)-Ruxolitinib-d9 CAS No.2469553-67-9 | (Rac)-Ruxolitinib D9 ((Rac)-INCB18424 D9)/CAS No.2469553-67-9 is the deuterium labeled (Rac)-Ruxolitinib. (Rac)-Ruxolitinib is a JAK2 inhibitor. | price> |

Items-$0.00

Email:
Tel.:
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


